522 related articles for article (PubMed ID: 20932661)
1. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
3. The accuracy of meningioma grading: a 10-year retrospective audit.
Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
5. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
[TBL] [Abstract][Full Text] [Related]
6. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
[TBL] [Abstract][Full Text] [Related]
8. Treatment of atypical meningioma.
Jo K; Park HJ; Nam DH; Lee JI; Kong DS; Park K; Kim JH
J Clin Neurosci; 2010 Nov; 17(11):1362-6. PubMed ID: 20800497
[TBL] [Abstract][Full Text] [Related]
9. Correlation of DNA content and nucleomorphometric features with World Health Organization grading of meningiomas.
Grunewald JP; Röhl FW; Kirches E; Dietzmann K
Mod Pathol; 1998 Feb; 11(2):216-23. PubMed ID: 9504694
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy.
Tanzler E; Morris CG; Kirwan JM; Amdur RJ; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):508-13. PubMed ID: 20452142
[TBL] [Abstract][Full Text] [Related]
11. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.
Simon M; Boström J; Koch P; Schramm J
J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):767-73. PubMed ID: 16306156
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for atypical meningiomas.
Mair R; Morris K; Scott I; Carroll TA
J Neurosurg; 2011 Oct; 115(4):811-9. PubMed ID: 21699480
[TBL] [Abstract][Full Text] [Related]
13. Atypical meningiomas: WHO moved the goalposts?
Smith SJ; Boddu S; Macarthur DC
Br J Neurosurg; 2007 Dec; 21(6):588-92. PubMed ID: 18071986
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
Bollag RJ; Vender JR; Sharma S
Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
Mahzouni P; Movahedipour M
Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
[TBL] [Abstract][Full Text] [Related]
16. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
Weber DC; Schneider R; Goitein G; Koch T; Ares C; Geismar JH; Schertler A; Bolsi A; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):865-71. PubMed ID: 22138457
[TBL] [Abstract][Full Text] [Related]
17. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin predicts the behaviour of atypical meningioma.
Lin CK; Tsai WC; Lin YC; Hueng DY
Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290
[TBL] [Abstract][Full Text] [Related]
19. Fractionated proton radiotherapy for benign cavernous sinus meningiomas.
Slater JD; Loredo LN; Chung A; Bush DA; Patyal B; Johnson WD; Hsu FP; Slater JM
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e633-7. PubMed ID: 22768992
[TBL] [Abstract][Full Text] [Related]
20. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
